These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4604756)

  • 1. Mesolimbic involvement with behavioural effects indicating antipsychotic activity.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Jun; 27(1):46-58. PubMed ID: 4604756
    [No Abstract]   [Full Text] [Related]  

  • 2. The nucleus amygdaloideus centralis and neuroleptic activity in the rat.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1974 Feb; 25(2):138-46. PubMed ID: 4154850
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of various neuroleptic drugs on noise escape response in rats.
    Niemegeers CJ; Verbruggen FJ; Janssen PA
    Psychopharmacologia; 1970; 18(3):249-59. PubMed ID: 5530581
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?
    Costall B; Naylor RJ
    Psychopharmacologia; 1973; 32(2):161-70. PubMed ID: 4796282
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
    Maj J; Sowińska H; Baran L; Sarnek J
    Eur J Pharmacol; 1974 Apr; 26(1):9-14. PubMed ID: 4857604
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of oxyprothepin enanthate and fluphenazine enanthate on the EEG and behaviour in rabbits.
    Likovský Z; Votava Z; Dlabac A
    Act Nerv Super (Praha); 1972; 14(2):127-8. PubMed ID: 5040160
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine's anti-acetylcholine property modulates its antistereotypic action in the mesolimbic system.
    Al-Shabibi UM; Doggett NS
    J Pharm Pharmacol; 1980 May; 32(5):359-61. PubMed ID: 6104704
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial restoration by a neuroleptic (spiramide) of items of grooming behaviour suppressed by amphetamine.
    Kjellberg B; Randrup A
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):61-6. PubMed ID: 4474849
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacology of neuroleptics upon repeated administration.
    Moller Nielsen I; Fjalland B; Pedersen V; Nymark M
    Psychopharmacologia; 1974 Jan; 34(2):95-104. PubMed ID: 4856370
    [No Abstract]   [Full Text] [Related]  

  • 12. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
    Gustafsson B; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():12-7. PubMed ID: 1968250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in dopamine agonist and antagonist activity following temporary inactivation of the neostraitum.
    Costall B; Naylor RJ; Pettit JC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(2):103-26. PubMed ID: 4281065
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of narcotic analgesics with neuroleptics on behavioral measures of dopaminergic activity.
    Lal H; Gianutsos G; Puri SK
    Life Sci; 1975 Jul; 17(1):29-34. PubMed ID: 238089
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of neuroleptic agents in the chronic pharmacological experiment].
    Stille G; Lauener H
    Arzneimittelforschung; 1974 Sep; 24(9):1292-4. PubMed ID: 4479794
    [No Abstract]   [Full Text] [Related]  

  • 16. The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents.
    Costall B; Naylor RJ
    Neuropharmacology; 1974 May; 13(5):353-64. PubMed ID: 4607196
    [No Abstract]   [Full Text] [Related]  

  • 17. Morphine induced stereotypic behavior in rat.
    Charness ME; Amit Z; Taylor M
    Behav Biol; 1975 Jan; 13(1):71-80. PubMed ID: 1167447
    [No Abstract]   [Full Text] [Related]  

  • 18. Reactions to apomorphine and spiroperidol of rats with striatal lesions: the relevance of kind and size of the lesion.
    Wolfarth S
    Pharmacol Biochem Behav; 1974; 2(2):181-6. PubMed ID: 4597891
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose-response shifts in the behavioural effects of dopamine agonists and antagonists following chronic morphine treatment.
    Overstreet DH; Smee ML; Woolston ME
    Proc West Pharmacol Soc; 1976; 19():248-53. PubMed ID: 1033554
    [No Abstract]   [Full Text] [Related]  

  • 20. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
    Voith K; Herr F
    Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.